Gender and ethnic differences in incidence and survival of lymphoid neoplasm subtypes in an Asian population: Secular trends of a population-based cancer registry from 1998 to 2012

被引:24
|
作者
Lim, Raymond Boon Tar [1 ,2 ]
Loy, En Yun [1 ]
Lim, Gek Hsiang [1 ]
Zheng, Huili [1 ]
Chow, Khuan Yew [1 ]
Lim, Soon Thye [3 ,4 ]
机构
[1] Natl Registry Dis Off, Hlth Promot Board, Singapore 168937, Singapore
[2] Natl Univ Singapore, Saw Swee Hock Sch Publ Hlth, Singapore 117548, Singapore
[3] SingHealth, Natl Canc Ctr Singapore, Singapore, Singapore
[4] Duke Natl Univ Singapore, Grad Sch Med, Singapore, Singapore
关键词
lymphoid neoplasm; lymphoma; incidence; survival; cancer registry; Singapore; NON-HODGKINS-LYMPHOMA; B-CELL LYMPHOMA; CHRONIC LYMPHOCYTIC-LEUKEMIA; MALIGNANT-LYMPHOMA; HEALTH; EPIDEMIOLOGY; RITUXIMAB; EUROPE; RISK; CLASSIFICATION;
D O I
10.1002/ijc.29635
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Descriptive epidemiology on incidence and survival by lymphoid neoplasm (LN) subtypes using the 2008 World Health Organisation (WHO) classification remained limited in Asia. The aim of this study was to evaluate whether gender and ethnic differences in incidence and survival of LN subtypes existed using the Singapore Cancer Registry (SCR) from 1998 to 2012. We derived age standardised incidence rates (ASIRs) by the direct standardisation method and 5-year relative survival (RSR) by the Ederer II method and period approach. Five-year observed survival (OS) was obtained for each ethnicity. Malays had the highest ASIR of total LNs among the three ethnicities for each time period. The largest increase in 5-year RSR subtypes was follicular lymphoma from 43.8% in 1998-2002 to 82.3% in 2008-2012; followed by chronic lymphocytic leukaemia (CLL)/small lymphocytic lymphoma (SLL) from 48.1% in 1998-2002 to 77.9% in 2008-2012. Although males had higher incidence than females in each time period, females had greater 5-year RSR for follicular lymphoma (89.8% in 2008-2012 for females vs. 76.6% in 2008-2012 for males) and CLL/SLL (78.7% in 2008-2012 for females vs. 76.7% in 2008-2012 for males). All three ethnicities experienced an overall increase in 5-year OS for mature B-cell lymphoma, with Indians experiencing the greatest increase (37.1% in 1998-2002 to 61.1% in 2008-2012), followed by Malays (30.8% in 1998-2002 to 48.7% in 2008-2012) and then Chinese (36.4% in 1998-2002 to 51.3% in 2008-2012). Our study demonstrated that improved mature B-cell lymphoma survival was not only observed in the West, but also in Singapore.
引用
收藏
页码:2674 / 2687
页数:14
相关论文
共 50 条
  • [1] Secular trends and population differences in the incidence of epilepsy. A population-based study from Saskatchewan, Canada
    Hernandez-Ronquillo, Lizbeth
    Thorpe, Lilian
    Pahwa, Punam
    Tellez-Zenteno, Jose F.
    SEIZURE-EUROPEAN JOURNAL OF EPILEPSY, 2018, 60 : 8 - 15
  • [2] Trends in incidence, mortality and survival in women with breast cancer from 1985 to 2012 in Granada, Spain: a population-based study
    Antonio Baeyens-Fernandez, Jose
    Molina-Portillo, Elena
    Pollan, Marina
    Rodriguez-Barranco, Miguel
    Del Moral, Rosario
    Arribas-Mir, Lorenzo
    Sanchez-Cantalejo Ramirez, Emilio
    Sanchez, Maria-Jose
    BMC CANCER, 2018, 18
  • [3] Trends in survival of ALS from a population-based registry
    Bianchi, Elisa
    Pupillo, Elisabetta
    De Feudis, Antonio
    Enia, Gabriele
    Vitelli, Eugenio
    Beghi, Ettore
    AMYOTROPHIC LATERAL SCLEROSIS AND FRONTOTEMPORAL DEGENERATION, 2022, 23 (5-6) : 344 - 352
  • [4] Secular decreasing trends in gastric cancer incidence in Taiwan: A population-based cancer registry study
    Lin, Yen-Tzeng
    Chiang, Chun-Ju
    Yang, Ya-Wen
    Huang, Shih-Pei
    You, San-Lin
    WORLD JOURNAL OF GASTROENTEROLOGY, 2021, 27 (34) : 5764 - 5774
  • [5] The heterogeneity of changes in incidence and survival among lymphoid malignancies in a 30-year French population-based registry
    Dandoit, Mylene
    Mounier, Morgane
    Guy, Julien
    Petrella, Tony
    Girard, Stephanie
    Casasnovas, Rene-Olivier
    Martin, Laurent
    Bonnetain, Franck
    Maynadie, Marc
    LEUKEMIA & LYMPHOMA, 2015, 56 (04) : 1050 - 1057
  • [6] Cancer incidence in Ghana, 2012: evidence from a population-based cancer registry
    Dennis O Laryea
    Baffour Awuah
    Yaw A Amoako
    E Osei-Bonsu
    Joslin Dogbe
    Rita Larsen-Reindorf
    Daniel Ansong
    Kwasi Yeboah-Awudzi
    Joseph K Oppong
    Thomas O Konney
    Kwame O Boadu
    Samuel B Nguah
    Nicholas A Titiloye
    Nicholas O Frimpong
    Fred K Awittor
    Iman K Martin
    BMC Cancer, 14
  • [7] Cancer incidence in Ghana, 2012: evidence from a population-based cancer registry
    Laryea, Dennis O.
    Awuah, Baffour
    Amoako, Yaw A.
    Osei-Bonsu, E.
    Dogbe, Joslin
    Larsen-Reindorf, Rita
    Ansong, Daniel
    Yeboah-Awudzi, Kwasi
    Oppong, Joseph K.
    Konney, Thomas O.
    Boadu, Kwame O.
    Nguah, Samuel B.
    Titiloye, Nicholas A.
    Frimpong, Nicholas O.
    Awittor, Fred K.
    Martin, Iman K.
    BMC CANCER, 2014, 14
  • [8] Cancer of the paranasal sinuses in Germany: Data on incidence and survival from a population-based cancer registry
    Nachtsheim, Lisa
    Moeller, Lennart
    Oesterling, Florian
    Kajueter, Hiltraud
    Stang, Andreas
    Hieggelke, Lena
    Abing, Helen
    Sharma, Jenny Shachi
    Klussmann, Jens Peter
    Mayer, Marcel
    Wolber, Philipp
    CANCER EPIDEMIOLOGY, 2024, 93
  • [9] Trends in incidence and survival analysis in non-melanoma skin cancer from 1994 to 2012 in Girona, Spain: A population-based study
    Rubio-Casadevalla, J.
    Hernandez-Pujol, A. M.
    Ferreira-Santos, M. C.
    Morey-Esteve, G.
    Vilardell, L.
    Osca-Gelis, G.
    Vilar-Coromina, N.
    Marcos-Gragera, R.
    CANCER EPIDEMIOLOGY, 2016, 45 : 6 - 10
  • [10] Trends in incidence, mortality and survival in women with breast cancer from 1985 to 2012 in Granada, Spain: a population-based study
    José Antonio Baeyens-Fernández
    Elena Molina-Portillo
    Marina Pollán
    Miguel Rodríguez-Barranco
    Rosario Del Moral
    Lorenzo Arribas-Mir
    Emilio Sánchez-Cantalejo Ramírez
    María-José Sánchez
    BMC Cancer, 18